Dr. Reddy's Laboratories Limited

NSE: DRREDDY · Healthcare

₹1,193.50
+3.50 (+0.29%)

Last close · 30 Aug 2026, 7:39 am IST

Open
₹1,189.00
Day high
₹1,193.50
Day low
₹1,175.00
Volume
15.70 L
Prev close
₹1,190.00

Price chart

Range
EMA
Also show

Fundamentals

Drug Manufacturers - Specialty & Generic

Valuation

Market Cap
95,937 Cr
Price
1,151.70
P/E (TTM)
28.99
P/E (Fwd)
19.10
P/B
2.50
EV/EBITDA
17.44
EV/Revenue
2.88
PEG
1.62
Div Yield
0.69%
52W High
1,414.90
52W Low
1,101.00
Beta
0.26

Profitability & income

Revenue (TTM)
33,119 Cr
Net Income (TTM)
3,311 Cr
EBITDA
5,467 Cr
Gross Margin
50.18%
Op. Margin
4.25%
Net Margin
10.00%
ROE
8.84%
ROA
4.01%
EPS (TTM)
39.73
EPS (Fwd)
60.30

Financial health

Total Debt
7,195 Cr
Total Cash
8,143 Cr
Debt/Equity
18.61
Current Ratio
1.90
Quick Ratio
1.16
Book Value
460.31
Free Cash Flow
-391 Cr
Op. Cash Flow
4,120 Cr

Growth

Revenue Growth
-5.60%
Earnings Growth
-68.70%
Earnings QoQ
-68.70%

Quarterly results

PeriodRevenueNet IncomeEBITDAOp. IncomeGross ProfitOp. Cash FlowTotal DebtEquity
2026-06-308,071 Cr444 Cr1,215 Cr303 Cr3,754 Cr-93 Cr7,195 Cr38,343 Cr
2026-03-317,516 Cr221 Cr863 Cr83 Cr4,304 Cr1,565 Cr7,734 Cr37,706 Cr
2025-12-318,727 Cr1,210 Cr2,159 Cr1,433 Cr4,681 Cr1,091 Cr6,773 Cr37,237 Cr
2025-09-308,805 Cr1,437 Cr2,431 Cr1,787 Cr4,814 Cr1,557 Cr5,854 Cr35,849 Cr
2025-06-308,545 Cr1,418 Cr2,464 Cr1,684 Cr4,863 Cr1,463 Cr4,864 Cr35,006 Cr
2025-03-31
2024-12-31

Annual results

PeriodRevenueNet IncomeEBITDAOp. IncomeGross ProfitOp. Cash FlowTotal DebtEquity
2026-03-3133,593 Cr4,285 Cr7,916 Cr5,012 Cr17,726 Cr5,676 Cr7,734 Cr37,706 Cr
2025-03-3132,554 Cr5,654 Cr9,667 Cr7,201 Cr19,043 Cr4,643 Cr4,677 Cr33,339 Cr
2024-03-3127,916 Cr5,568 Cr8,842 Cr6,531 Cr16,361 Cr4,543 Cr2,002 Cr28,055 Cr
2023-03-3124,588 Cr4,507 Cr7,443 Cr5,905 Cr13,934 Cr5,888 Cr1,347 Cr23,099 Cr
2022-03-31

Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.

Want charts and signals for DRREDDY?

Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.

Sign in